CEO, Robert L. Cucin is interviewed by Michael Yorba on the I Heart Radio’s “Traders Network Show” on April 11, 2015.
Dr. Cucin discusses the rationale and potential of the endoscopic visceral lipectomy methods and devices the company is developing for the treatment of obesity, metabolic syndrome and type 2 diabetes.